Actin-Binding LIM 1 (ABLIM1) Inhibits Glioblastoma Progression and Serves as a Novel Prognostic Biomarker

Table 2

Cancer-specific survival analyses of GBM patients.

Variables	Cases	Univariate analysis		Multivariate analysis
	()	3-Y CSS rate	value	HR (95% CI)	value
Age
<62 yrs	51	53.7%		Reference
≥62 yrs	53	11.8%	<0.001	2.7 (1.6-4.6)	<0.001
Sex
Female	51	33.6%
Male	53	34.4%	0.512
Tumor size
<4.0 cm	53	44.5%		Reference
≥4.0 cm	51	24.0%	0.031	1.1 (0.6-1.8)	0.812
Resection pattern
Local resection	55	32.9%
Radical resection	20	35.9%
Lobectomy	29	35.9%	0.585
Chemotherapy
No or unknown	85	41.8%
Yes	19	6.7%	0.204
ABLIM1 level
Low	56	12.4%		Reference
High	48	54.7%	<0.001	0.3 (0.2-0.6)	<0.001

by log-rank test. . Abbreviations: ABLIM1; actin-binding LIM protein 1; CI: confidence interval; CSS: cancer-specific survival; GBM: glioblastoma; HR: hazard ratio.